This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Weyant, M. J. Articles by Bertagnolli, M. M. Search for Related Content PubMed PubMed Citation Articles by Weyant, M. J. Articles by Bertagnolli, M. M.

Colon Cancer Chemopreventive Drugs Modulate Integrin-mediated Signaling Pathways¹

Department of Surgery, The New York Presbyterian Hospital-Weill Cornell Medical Center and James E. Olson GI Cancer Center, Strang Cancer Prevention Center, New York, New York 10021 [M. J.W., A. M. C.]; Department of Biochemistry, Gonzaga University, Spokane, Washington 99258 [M. E. B.]; and Department of Surgery, Brigham and Women’s Hospital, Boston, Massachusetts 02115 [M. M. B.]

Epidemiological studies of colorectal cancer incidence suggest that the development of this disease can be modulated by dietary factors. Among the micronutrients showing significant efficacy in tumor prevention are polyphenolic antioxidants found in fruits and vegetables. Epidemiological studies also indicate that nonsteroidal anti-inflammatory drugs (NSAIDs) decrease the incidence of colorectal cancer. Integrin-mediated cell-matrix contact provides critical signaling that regulates cellular proliferation, migration, and apoptosis. A signaling mediator for this system is focal adhesion kinase (FAK). Thus far, FAK has not been identified as a target for the inhibitory action of any chemopreventive drug in vivo or in vitro. However, the loss of integrin-mediated cell-matrix contact can induce apoptosis (anoikis), and effective chemopreventive agents typically increase the rate of enterocyte apoptosis. Therefore, we asked whether the NSAID, sulindac sulfide, and the phenolic antioxidant, caffeic acid phenethyl ester (CAPE), affected FAK expression or tyrosine phosphorylation in human colon carcinoma cells. We show that subapoptotic doses of both sulindac sulfide and CAPE caused a rearrangement of the actin cytoskeleton and consequently the loss of focal adhesion plaques. These drugs also reduced the tyrosine phosphorylation of FAK and an associated factor, p130^cas. Steady-state levels of these proteins, together with other relevant signaling molecules, remained unchanged after treatments. Finally, we show that both CAPE and sulindac reduced cell invasion, a functional assay for the inhibition of signaling downstream of FAK. These data strongly suggest that chemopreventive drugs can regulate FAK activity. In conclusion, these novel studies add modulation of integrin-mediated signaling to the spectrum of activity of NSAIDs and plant phenolics.

This article has been cited by other articles:

				G. D. Minsavage and J. F. Dillman III Bifunctional Alkylating Agent-Induced p53 and Nonclassical Nuclear Factor {kappa}B Responses and Cell Death Are Altered by Caffeic Acid Phenethyl Ester: A Potential Role for Antioxidant/Electrophilic Response-Element Signaling J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 202 - 212. [Abstract] [Full Text] [PDF]

				M. L. Nystrom, D. McCulloch, P. H. Weinreb, S. M. Violette, P. M. Speight, J. F. Marshall, I. R. Hart, and G. J. Thomas Cyclooxygenase-2 Inhibition Suppresses {alpha}v{beta}6 Integrin-Dependent Oral Squamous Carcinoma Invasion. Cancer Res., November 15, 2006; 66(22): 10833 - 10842. [Abstract] [Full Text] [PDF]

				O. K. Glebov, L. M. Rodriguez, P. Lynch, S. Patterson, H. Lynch, K. Nakahara, J. Jenkins, J. Cliatt, C.-J. Humbyrd, J. DeNobile, et al. Celecoxib treatment alters the gene expression profile of normal colonic mucosa. Cancer Epidemiol. Biomarkers Prev., July 1, 2006; 15(7): 1382 - 1391. [Abstract] [Full Text] [PDF]

				A. M. Carothers, A. E. Moran, N. L. Cho, M. Redston, and M. M. Bertagnolli Changes in Antitumor Response in C57BL/6J-Min/+ Mice during Long-term Administration of a Selective Cyclooxygenase-2 Inhibitor. Cancer Res., June 15, 2006; 66(12): 6432 - 6438. [Abstract] [Full Text] [PDF]

				L A A Brosens, J J Keller, G J A Offerhaus, M Goggins, and F M Giardiello Prevention and management of duodenal polyps in familial adenomatous polyposis Gut, July 1, 2005; 54(7): 1034 - 1043. [Full Text] [PDF]

				S. H. Javid, A. E. Moran, A. M. Carothers, M. Redston, and M. M. Bertagnolli Modulation of tumor formation and intestinal cell migration by estrogens in the ApcMin/+ mouse model of colorectal cancer Carcinogenesis, March 1, 2005; 26(3): 587 - 595. [Abstract] [Full Text] [PDF]

				A. E. Moran, D. H. Hunt, S. H. Javid, M. Redston, A. M. Carothers, and M. M. Bertagnolli Apc Deficiency Is Associated with Increased Egfr Activity in the Intestinal Enterocytes and Adenomas of C57BL/6J-Min/+ Mice J. Biol. Chem., October 8, 2004; 279(41): 43261 - 43272. [Abstract] [Full Text] [PDF]

				S. Nakahara, E. Miyoshi, K. Noda, S. Ihara, J. Gu, K. Honke, H. Inohara, T. Kubo, and N. Taniguchi Involvement of oligosaccharide changes in {alpha}5{beta}1 integrin in a cisplatin-resistant human squamous cell carcinoma cell line Mol. Cancer Ther., November 1, 2003; 2(11): 1207 - 1214. [Abstract] [Full Text] [PDF]

				I. L. Szabo, R. Pai, M. K. Jones, G. R. Ehring, H. Kawanaka, and A. S. Tarnawski Indomethacin Delays Gastric Restitution: Association with the Inhibition of Focal Adhesion Kinase and Tensin Phosphorylation and Reduced Actin Stress Fibers Experimental Biology and Medicine, June 1, 2002; 227(6): 412 - 424. [Abstract] [Full Text] [PDF]

				D. Ilic, O. Genbacev, F. Jin, E. Caceres, E. A. C. Almeida, V. Bellingard-Dubouchaud, E. M. Schaefer, C. H. Damsky, and S. J. Fisher Plasma Membrane-Associated pY397FAK Is a Marker of Cytotrophoblast Invasion in Vivo and in Vitro Am. J. Pathol., July 1, 2001; 159(1): 93 - 108. [Abstract] [Full Text] [PDF]

				M. J. Weyant, A. M. Carothers, N. N. Mahmoud, H. L. Bradlow, H. Remotti, R. T. Bilinski, and M. M. Bertagnolli Reciprocal Expression of ER{{alpha}} and ER{beta} Is Associated with Estrogen-mediated Modulation of Intestinal Tumorigenesis Cancer Res., March 1, 2001; 61(6): 2547 - 2551. [Abstract] [Full Text]

				M. J. Weyant, A. M. Carothers, A. J. Dannenberg, and M. M. Bertagnolli (+)-Catechin Inhibits Intestinal Tumor Formation and Suppresses Focal Adhesion Kinase Activation in the Min/+ Mouse Cancer Res., January 1, 2001; 61(1): 118 - 125. [Abstract] [Full Text]